Brooklyn ImmunoTherapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BTX and other ETFs, options, and stocks.

About BTX

Brooklyn ImmunoTherapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B. 

CEO
Matthew Angel
CEOMatthew Angel
Employees
10
Employees10
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1984
Founded1984
Employees
10
Employees10

BTX Key Statistics

Market cap
15.26M
Market cap15.26M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
614.84K
Average volume614.84K
High today
$0.2699
High today$0.2699
Low today
$0.2246
Low today$0.2246
Open price
$0.23
Open price$0.23
Volume
405.18K
Volume405.18K
52 Week high
$10.10
52 Week high$10.10
52 Week low
$0.21
52 Week low$0.21

BTX Earnings

-$0.29
-$0.19
-$0.10
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 17, Pre-Market
ActualExpected Nov 17, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.